The 5-mg vial of Humatrope should be reconstituted with 1.5-5 mL of sterile diluent (0,3% Metacresol as preservative and 1,7% glycerin)
Gojkovic S, Krezic I, Vranes H et al (2021) Bpc 157 therapy and the permanent occlusion of the superior sagittal sinus in rat: Vascular recruitment
Increased Angiogenesis at the Injury Site: New capillary network formation accelerates in BPC-157-treated connective tissue through VEGF upregulation, supplying the vascularization required for sustained cellular repair activity
In most states, once someone reaches 0.08, they legally cannot drive
Final Word BPC-157 may well prove to be one of the most important tools in sports medicine and regenerative care
Documentation of the injection should be included in the patient's medical record, and the patient should be informed about the possible side effects of the medication